Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Ley

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Genome Research|October 12, 2010
Next-generation sequencing identifies the natural killer cell microRNA transcriptomeTodd A Fehniger, Todd Wylie, Elizabeth Germino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewingShamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Blood|September 30, 2022
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertionsGeorgina L Ryland, Masayuki Umeda, Linda Holmfeldt, et al.
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Genome Research|October 12, 2010
Next-generation sequencing identifies the natural killer cell microRNA transcriptomeTodd A Fehniger, Todd Wylie, Elizabeth Germino, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2020
Remethylation of <i>Dnmt3a</i><sup>-/-</sup> hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewingShamika Ketkar, Angela M Verdoni, Amanda M Smith, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Blood|July 27, 2022
Proteomic and phosphoproteomic landscapes of acute myeloid leukemiaMichael H Kramer, Qiang Zhang, Robert Sprung, et al.
Nature|October 18, 2013
Mutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D McLellan, Fabio Vandin, et al.
Blood|September 30, 2022
Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertionsGeorgina L Ryland, Masayuki Umeda, Linda Holmfeldt, et al.
Haematologica|March 3, 2022
Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapyFrancesca Ferraro, Agata Gruszczynska, Marianna B Ruzinova, et al.
Nature Medicine|October 20, 2014
Age-related mutations associated with clonal hematopoietic expansion and malignanciesMingchao Xie, Charles Lu, Jiayin Wang, et al.
Pageof 16